Surgeon-Pathologist Team Approach Dramatically Affects Lymph Nodes Detection and Improves Patients' Short-Term Outcome.
downstaging
gastric cancer
lymph node harvesting
skip metastasis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
18 Feb 2022
18 Feb 2022
Historique:
received:
27
12
2021
revised:
07
02
2022
accepted:
11
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
The downstaging of gastric cancer has recently gained particular attention in the field of gastric cancer surgery. The phenomenon is mainly due to an inappropriate sampling of lymph nodes during standard lymphadenectomy. Hence, collection of the maximum number of lymph nodes is a critical factor affecting the outcome of patients. None of the techniques proposed so far have demonstrated a real efficiency in increasing the number of identified lymph nodes. To harvest the maximum number of lymph nodes, we designed a protocol for on-site macroscopic evaluation and sampling of lymph nodes according to the Japanese Gastric Cancer Association protocol. The procedure was carried out by a surgeon/pathologist team in the operating room. We enrolled one hundred patients, 50 of whom belonged to the study group and 50 to a control group. The study group included patients who underwent lymph node dissection following the proposed protocol; the control group encompassed patients undergoing standard procedures for sampling. We compared the number and maximum diameter of lymph nodes collected in both groups, as well as some postoperative variables, the 30-day mortality and the overall survival. In the study group, the mean number of lymph nodes harvested was higher than the control one (
Identifiants
pubmed: 35205783
pii: cancers14041034
doi: 10.3390/cancers14041034
pmc: PMC8870551
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
World J Surg Oncol. 2018 Oct 4;16(1):198
pubmed: 30286762
Ann Surg Oncol. 2017 Apr;24(4):998-1002
pubmed: 27830390
J Gastric Cancer. 2018 Jun;18(2):161-171
pubmed: 29984066
BMC Gastroenterol. 2021 Jan 6;21(1):15
pubmed: 33407177
BMC Cancer. 2018 Jan 12;18(1):73
pubmed: 29329569
Updates Surg. 2020 Dec;72(4):1031-1040
pubmed: 32388806
Updates Surg. 2018 Jun;70(2):197-205
pubmed: 29926307
Ann Transl Med. 2020 Sep;8(17):1075
pubmed: 33145294
Sci Rep. 2019 Dec 16;9(1):19186
pubmed: 31844139
World J Gastrointest Surg. 2020 Jun 27;12(6):277-286
pubmed: 32774766
Gastric Cancer. 2017 May;20(3):448-456
pubmed: 27586236
Transl Gastroenterol Hepatol. 2017 Feb 20;2:10
pubmed: 28275742
Updates Surg. 2021 Oct;73(5):2025-2028
pubmed: 33961278
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
Cancers (Basel). 2021 Jul 24;13(15):
pubmed: 34359622
Eur J Surg Oncol. 2011 Apr;37(4):305-11
pubmed: 21288685
Int J Surg Oncol. 2011;2011:748745
pubmed: 22312521
Gastric Cancer. 2021 Jan;24(1):1-21
pubmed: 32060757
Eur J Surg Oncol. 2020 Oct;46(10 Pt B):e14-e19
pubmed: 32732091
Int J Surg. 2014;12(7):725-8
pubmed: 24851719
Ann Surg Oncol. 2020 Oct;27(11):4235-4247
pubmed: 32424582
Gastric Cancer. 2019 Jul;22(4):853-863
pubmed: 30483985
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Sci Rep. 2021 Jan 21;11(1):2022
pubmed: 33479327
J Am Coll Surg. 2017 Apr;224(4):546-555
pubmed: 28017807
Transl Gastroenterol Hepatol. 2020 Apr 05;5:17
pubmed: 32258521
J BUON. 2020 Jan-Feb;25(1):319-323
pubmed: 32277649
Histopathology. 2012 Oct;61(4):531-42
pubmed: 23551433
J Cancer. 2019 Sep 7;10(23):5646-5653
pubmed: 31737101
Updates Surg. 2020 Sep;72(3):761-772
pubmed: 32607845
Cancer Commun (Lond). 2019 Sep 13;39(1):49
pubmed: 31519217
Gastric Cancer. 2012 Sep;15 Suppl 1:S70-88
pubmed: 22895615
World J Gastroenterol. 2010 Jul 21;16(27):3358-70
pubmed: 20632437
Updates Surg. 2018 Jun;70(2):189-195
pubmed: 29869322
Front Surg. 2018 Oct 18;5:63
pubmed: 30406109